Anagenex
Guiding a First-Time CEO with Strategic Insights to Accelerate Organizational and Business Growth
Anagenex is a pre-clinical biotechnology innovator advancing drug discovery through its small molecule (directed evolution) platform. The company’s unique ML-driven technology enables Anagenex to discover first-in-class and best-in-class small molecule medicines addressing historically intractable targets. This case study explores how strategic guidance can help a first-time CEO navigate the complexities of scaling a biotech company, aligning organizational structure, sharpening decision-making, and accelerating business growth.
THE CHALLENGE
Anagenex had relatively little in the way of organizational structure or funding in place when Occam was engaged.
The task was to help create a framework around which first-time CEO Nicolas Tilmans could begin to realize his scientific ambitions to disrupt the way small-molecule drugs are discovered at scale. At the same time, we provided him with strategic guidance around board construction.
THE SOLUTION
Building a High-Impact Scientific and Technical Executive Bench:
Occam expanded the leadership team, strengthening both scientific and technical depth.
Sharpening Organizational Strategy:
Our biotech executive search and leadership advisory empowered a first-time CEO, accelerating growth while reinforcing the company’s structural foundation.
Contact us today to build your life science executive team and define your next strategic move.
THE IMPACT
Faster Scale and Growth:
Occam’s targeted executive search and advisory approach gave Anagenex the leadership strength and organizational clarity to transition from early-stage ambiguity to disciplined, scalable growth.
Enhanced Investment Positioning:
Assembled a high-impact board and executive team, driving sharper decision-making and positioning the company to advance innovation and attract strategic investment.
IN SUMMARY
We played a pivotal role in advancing Anagenex’s evolution from an early-stage innovator to a high-growth techbio company, strengthening its leadership to match the ambition of its science. Our strategic biotech executive search and advisory approach helps emerging companies accelerate their path to breakthrough innovation and sustained impact.
Contact us today to build your life science executive team.
CONTACT US TO HELP BUILD YOUR LIFE SCIENCE EXECUTIVE TEAM.
FAQ
LEARN MORE ABOUT OUR DISTINCTIVE APPROACH
Does AI threaten executive search careers?
Less than most professions. AI can assist with sourcing and data, but the core of the work — building trust, navigating conflicting stakeholders, and judging how a leader will perform in a specific context — depends on human capabilities AI does not have. This makes the work relatively resilient to automation.
Can a new graduate go into executive search directly, without consulting first?
There’s no single required path. Strong analytical training, clear writing, comfort with ambiguity, and genuine curiosity about people are the real common denominators. Having an MBA is frequently valued because the underlying skills transfer directly but the traits matter more than any one credential.
How is executive search different from recruiting?
High-level executive search is strategic advisory work focused on leadership selection at pivotal moments, placing CEOs, executives, and board members, and advising founders and boards. It involves far more judgment, psychology, and strategic counsel than transactional recruiting, which centers on filling roles against a specification.
